Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Schmitt, M; Mengele, K; Napieralski, R; Magdolen, V; Reuning, U; Gkazepis, A; Sweep, F; Brünner, N; Foekens, J; Harbeck, N 
Titel:
Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. 
Abstract:
The prognostic and/or predictive value of the cancer biomarkers, urokinase-type plasminogen activator (uPA) and its inhibitor (plasminogen activator inhibitor [PAI]-1), determined by ELISA in tumor-tissue extracts, was demonstrated for several cancer types in numerous clinically relevant retrospective or prospective studies, including a multicenter breast cancer therapy trial (Chemo-N0). Consequently, for the first time ever for any cancer biomarker for breast cancer, uPA and PAI-1 have reached...    »
 
Zeitschriftentitel:
Expert Rev Mol Diagn 
Jahr:
2010 
Band / Volume:
10 
Heft / Issue:
Seitenangaben Beitrag:
1051-67 
Sprache:
eng 
Print-ISSN:
1473-7159 
TUM Einrichtung:
Frauenklinik und Poliklinik